Brief outlook about Zahraa

27

description

Brief outlook about Zahraa . Zahraa. Al Zahraa is a fast growing privately owned Egyptian company; established in 1994 with its main office in Cairo- Egypt. - PowerPoint PPT Presentation

Transcript of Brief outlook about Zahraa

Page 1: Brief outlook about Zahraa
Page 2: Brief outlook about Zahraa

Brief outlook about Zahraa

Page 3: Brief outlook about Zahraa

Al Zahraa is a fast growing privately owned Egyptian company; established in 1994 with its main office in Cairo- Egypt.

It was founded by a group of professionals, who spent a great deal of time learning and working in various pharmaceutical companies; and had a good professional experience in that field.

We are a fast growing Co. focusing on Importing, providing, and marketing medical oncology drugs and other therapeutic specialties of significant unmet medical drugs.

Zahraa

Page 4: Brief outlook about Zahraa

We started our activity as an agent for foreign suppliers in the field of active pharmaceutical ingredients”API”.

 We promote & distribute (API’s) to the Pharma industry (public & private sector).

In 2005, due to the growth and expanding fast of al-Zahraa& the market as well ,Al-Zahraa diversifies to two main Activities:-

1. a. Continuing our business in API’

2. b. Our new Activity in importing finished drugs, in the field of

oncology line.

Page 5: Brief outlook about Zahraa

On that base we have been granting the representation of reputable international companies from Switzerland &Germany

Representing them as an exclusive Sole Agent& distributer in Egypt for their generic

Page 6: Brief outlook about Zahraa

To be amongst the top providers of oncology specialty products in Egypt, Middle and North Africa.

Al Zahraa defines common values, goals and strategies for a better quality of life to human kind.

To occupy a leading market position in each of these specialty areas.

To maximize our profitability over the long term while our core of business continues to thrive and grow, our eyes is always on opportunities.

Al-Zahraa’s future challenges are truly existing, new products launches, market expansion, and competition among Multinationals.

Our Vision

Page 7: Brief outlook about Zahraa

“Health is something that connects us all”

“We are building a strong platform to serve our medical market and distinctively and competitively meet the ever changing demand in

health care. Focusing on our unique portfolio of quality medicines at well

designed and affordable prices.

Through our activities we touch a great number of people’s lives and we are acutely conscious of our responsibility to patients and society in general.

Our Mission

Page 8: Brief outlook about Zahraa

We are small; but very committed to growth; integrity and the values to our customers & our society.

We are dedicated to providing high medical value to physicians; patients and medical care organizations.

The clue is in our name” You have seen the word “Zahraa” but you never thought what this

name in the context of our mission is.

Page 9: Brief outlook about Zahraa

How you will create an added value and to who me ?

Our Unique business that we are working on is a niche market for only oncology products.

What we are best compared to our competitors; that our drugs is a very high quality with a better price.

Business Model

Page 10: Brief outlook about Zahraa

We are working on an incidence disease that is increasing yearly by 20% in Egypt, each year we have 100,000 new cancer patients.

We can be best on focusing on this target market, through our social responsibility through our society

We need to shore up the weaknesses, capitalize on the opportunities and recognize the threats.

Page 11: Brief outlook about Zahraa

ONCOLOGY PORTFOLIO

Page 12: Brief outlook about Zahraa

ANASTRAZOLE

Page 13: Brief outlook about Zahraa

ANTI HORMONAL DRUG :-

Form Strength Origin Country Company name Pack price l.E

Tablet box(30tab) 1mg Germany Haemato Pharm 310L.E

Page 14: Brief outlook about Zahraa
Page 15: Brief outlook about Zahraa

GEMCITABINE HCL

Page 16: Brief outlook about Zahraa

Anti metabolites: “ Gemci-Haemato“

Form Strength Origin Country Company Name pack price L.E

Vial 1g Germany Haemato Pharm 465L.E

Vial 200mg Germany Haemato Pharm 129L.E

Page 17: Brief outlook about Zahraa
Page 18: Brief outlook about Zahraa

PACLITAXEL

STRAGEN 6MG/ML

Page 19: Brief outlook about Zahraa

Anti mitotic:-

Form Strength Origin Country Company Name pack price L.E

Vial 30mg/5ml Switzerland Stragen Pharma S.A 195L.E

Vial 100mg/16.7ml Switzerland Stragen Pharma S.A 950L.E

Vial 150g/25ml Switzerland Stragen Pharma S.A 1600L.E

Vial 300mg/50ml Switzerland Stragen Pharma S.A 3000L.E

Page 20: Brief outlook about Zahraa
Page 21: Brief outlook about Zahraa

CYPROTERONE ACETATE

Page 22: Brief outlook about Zahraa

Anti androgen:-

Form Strength Origin Country Company Name pack price L.E

Tablet

Box(20tab)50mg United Kingdom Stragen UK Ltd. 80L.E

Page 23: Brief outlook about Zahraa
Page 24: Brief outlook about Zahraa
Page 25: Brief outlook about Zahraa

الصحة وزارةالشيخ 1. كفر الصحى التأمينالمنوفية 2. الصحى التأميندمياط 3. الصحى التأمين.4) المحلة ) - طنطا الغربية الصحى التأمين

للطيران مصر مستشفى القومى األورام معهد

ا*ع*م*******ا*ل س*********ا*ب*ق*ه*

Page 26: Brief outlook about Zahraa

ناصر معهد طنطا جامعة مستشفيات ) النووى ) والطب االورام مركز المنصورة جامعة بالشرقيه األورام مرضى أصدقاء جمعية( المس*لحة للقوات المعادى ( Donationمستشفى

Page 27: Brief outlook about Zahraa

للصيادلة المتحدة الشركةجميع فروع وصيدليات الشركة المتحدة للصيادلة المنتشرة فى

جمهورية مصر العربية ش سمير سيد احمد – المنيل – 14

القاهرة

الشركةالمصريةلتجارةاالدوية

جميع فروع وصيدليات الشركة المصرية لتجارة االدوية المنتشرة فى

جمهورية مصر العربية ش كورنيش النيل –الخلفاوى- 135

شبرا

التوزيع ش***ركات